Analyst Research

Report Title Price
Thomson Reuters Stock Report - TYRATECH, INC. (TYR-LN)
Provider: Thomson Reuters Stock Report
$25.00
Buy
TyraTech Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
TyraTech, Inc. (TYR) - Clean Technology - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
TyraTech, Inc. (TYR) - Financial Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

TyraTech Inc Receives Head Lice Product Registration In UK


Tuesday, 11 Dec 2012 02:00am EST 

TyraTech Inc announced that the Company has received notification from the U.K. regulatory body, the Medicines and Healthcare products Regulatory Agency (MHRA), that the Company's head lice product VaMOUSSE! has been registered with the MHRA as a Class I medical device. As a Class I medical device, VaMOUSSE! will be subject to the lowest level of regulatory oversight. 

Latest Developments for TyraTech Inc

Latest Key Developments in Chemicals

Company Quote

TyraTech Inc
(TYR.L)
5.0
0.5 +11.11%
19 Mar 2013